390 results on '"Rufer, Nathalie"'
Search Results
2. Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
3. Supplementary Table S2 from MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
4. Supplementary Figures and Table 1 from MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
5. Data from MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
6. Supplementary Fig. S2 from Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
7. Supplementary Table S1 from Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
8. Supplementary Methods, Supplementary Tables 1-2, Supplementary Figures 1-6 from Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients
9. Supplementary Materials and Methods from Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
10. Supplementary Materials and Methods from Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients
11. Supplementary Figure S2 from Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells
12. Data from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
13. Supplementary Figure Legends from Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells
14. Data from Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells
15. Supplementary Figure 1 from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
16. Supplementary Figure 3 from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
17. Supplementary Figure 2 from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
18. Successful outcome of pregnancy post‐allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report
19. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
20. Assessing T Cell Receptor Affinity and Avidity Against Tumor Antigens
21. Understanding the parameters guiding the best practice for treating B‐cell‐depleted patients with COVID ‐19 convalescent plasma therapy
22. Antibody response and intra‐host viral evolution after plasma therapy in COVID ‐19 patients pre‐exposed or not to B‐cell‐depleting agents
23. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity
24. Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes
25. Distinct Sets of αβ TCRs Confer Similar Recognition of Tumor Antigen NY-ESO-1₁₅₇₋₁₆₅ by Interacting with Its Central Met/Trp Residues
26. Unmodified Self Antigen Triggers Human CD8 T Cells with Stronger Tumor Reactivity than Altered Antigen
27. SHP-1 phosphatase activity counteracts increased T cell receptor affinity
28. Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose
29. Exhaustion of tumor-specific [CD8.sup.+] T cells in metastases from melanoma patients
30. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery
31. Constant regulation for stable CD8 T‐cell functional avidity and its possible implications for cancer immunotherapy
32. Distinct sets of [alpha][beta] TCRs confer similar recognition of tumor antigen [NY-ESO-1.sub.157-165] by interacting with its central Met/Trp residues
33. Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density
34. Two specific populations of GABAergic neurons originating from the medial and the caudal ganglionic eminences aid in proper navigation of callosal axons
35. MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
36. Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells
37. Methods for Human CD8+ T Lymphocyte Proteome Analysis
38. Stepwise anti-inflammatory and anti-SARS-CoV-2 effects following convalescent plasma therapy with full clinical recovery
39. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells
40. High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
41. Understanding the parameters guiding the best practice for treating B‐cell‐depleted patients with COVID‐19 convalescent plasma therapy.
42. Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma
43. Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density
44. Molecular tracking of antigen-specific T-cell clones during immune responses
45. Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor
46. MOESM1 of Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
47. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
48. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma
49. Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell-Associated Disorders
50. Limited Telomere Shortening in Hematopoietic Stem Cells after Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.